文献引用
-
1) Cinnamaldehyde-Based Self-Assembled Nanodrugs with GSH Depletion for Antitumor through Photodynamic Therapy Enhanced Ferroptosis and Immunotherapy.
-
2) Ultrasound-Responsive Cerasome Nanoparticle Improves STING-Driven Immunotherapy in Triple-Negative Breast Cancer.
-
3) Engineered haptoglobin β fusion protein targets myoglobin and ameliorates rhabdomyolysisassociated acute kidney injury.
-
4) Isorhamnetin attenuates lipopolysaccharide-induced myocardial inflammatory injury by inhibiting PPAR γ and preserving mitochondrial homeostasis.
-
5) Sema3dhi Fibroblasts Promote Acute Kidney Injury Fibrotic Progression Through Confining Endothelial Cell Migration.
-
6) Schisandrin B Targets PXR to Enhance Bile Acid Metabolism and Alleviate ANIT-Induced Cholestatic Liver Injury via Dual Pathways.
-
7) Classic Protocadherin PCDH10 Functions as a Tumor Suppressive Scaffold Protein Antagonizing Oncogenic WNT/β-catenin Signaling in Breast Carcinogenesis.
-
8) Abnormal mechanical load aggravates subchondral bone remodeling and uneven tibial plateau settlement in knee osteoarthritis via activation of osteoblast Piezo1-Ca²⁺-JAK2/STAT3 signaling.
-
9) Piezo1-Fstl1 Axis in Fracture Healing: Modulation of the Chondrocyte Inflammation-ROS-Mitochondrial Damage Cascade and Application of Smart Delivery System.
-
10) Developing tissue-engineered bone with pre-vascularization and innervation using a bottom-up approach involving MSC/EPC/SC microtissues.
-
11) SIRT1 activation restores PINK1-dependent mitophagy to reverse airway barrier dysfunction in Acinetobacter baumannii infection.
-
12) PTPN1 Regulation via YBX1-PTBP1 Interaction Promotes Fibroblast Activation and Fibrotic Remodeling in the Lung.
-
13) Targeting Macrophage-to-Myofibroblast Transition Mitigates Progression from Inflammation to Fibrosis in Rosacea.
-
14) CCL1-AMFR Facilitates Glioblastoma Progression by Modulating the Cross-talk between Glioma Cells and Tumor-Associated Macrophages.
-
15) ATGL suppresses ferroptosis in acute myeloid leukemia cells by modulating the CEBPα/SCD1 axis and induces gilteritinib resistance.